Chemo + Breast Cancer Combo Accelerates Functional Decline in Seniors
By Lori Solomon HealthDay Reporter
WEDNESDAY, May 29, 2024 -- The combination of breast cancer and chemotherapy contributes to accelerated functional decline in older women with early-stage breast cancer, according to a study published online April 28 in the Journal of Cancer Survivorship.
Mina S. Sedrak, M.D., from the University of California Los Angeles David Geffen School of Medicine, and colleagues assessed whether physical functional decline in older women with early-stage breast cancer is driven by cancer, chemotherapy, or a combination of both. Analysis included women aged 65 years and older with early-stage breast cancer receiving chemotherapy (BC chemo; 444 participants), early-stage breast cancer not receiving chemotherapy (BC control; 98 participants), and noncancer controls (100 participants).
The researchers found that the BC chemo group experienced a significant decline at time point 2 (three, four, or six months), with a median change in Physical Functioning Subscale (PF-10) of −5 (interquartile range [IQR], −20 to 0), while the BC control and noncancer control groups showed a median change of 0 (IQR, −5 to 5). Among BC chemo participants, more than 30 percent had a substantial decline in PF-10 compared to 8 percent in the BC control and 5 percent in the noncancer control groups.
"The high prevalence of accelerated functional decline in older women undergoing breast cancer chemotherapy underscores the urgency to develop interventions aimed at preserving physical function and improving health outcomes," the authors write.
Several authors disclosed ties to pharmaceutical companies.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians
FRIDAY, June 28, 2024 -- Almost 90 percent of medical centers report cancer drug shortages, which often impact clinical trials, according to the results of a National...
Acupuncture Reduces Endocrine Symptoms, Hot Flashes in Breast Cancer
MONDAY, June 24, 2024 -- A 10-week acupuncture intervention significant reduces endocrine symptoms and hot flashes among women with breast cancer receiving endocrine therapy (ET)...
Study Quantifies Risk for Gastric, Breast Cancer for Germline CDH1 P/LP Variants
FRIDAY, June 21, 2024 -- The cumulative risk for advanced gastric cancer varies from 6.5 to 10.3 percent for carriers of germline CDH1 pathogenic/likely pathogenic (P/LP)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.